Literature DB >> 16801420

Accelerated denaturation of hemoglobin and the antimalarial action of chloroquine.

Coy D Fitch1, Natrice V Russell.   

Abstract

To study the antimalarial action of chloroquine, normal mouse erythrocytes were used as surrogates for erythrocytoid bodies. These bodies form in the endosomes of intraerythrocytic malaria parasites as they feed on their host and consist of erythrocyte cytoplasm enclosed in a vestige of the erythrocyte membrane. In suspensions of normal erythrocytes or lysates (equivalent to 5 microl of erythrocytes per ml in each case), hemoglobin underwent denaturation when it was incubated at 38 degrees C in 150 mM sodium acetate (pH 5). It is reasonable to assume that the same phenomenon occurs in acidic endosomes. Addition of 100 microM chloroquine to the incubation mixture caused the rate of hemoglobin denaturation to double to 40 nanomoles per hour per ml of packed erythrocytes. This effect required the presence of erythrocyte stroma and was inhibited by reducing the temperature to 24 degrees C or increasing the pH to 6. We propose that the primary antimalarial action of chloroquine is to bind to ferriprotoporphyrin IX (FP) and remove it from oxidized hemoglobin, thus producing toxic FP-chloroquine complexes and an excess of denatured globin. Furthermore, we suggest that these substances inhibit endosomal maturation and thereby cause hemoglobin accumulation in immature endosomes and masking of the lipids needed for FP dimerization. The term "masking" is used to signify that unsaturated lipids are present in parasitized erythrocytes but are specifically unavailable to promote FP dimerization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801420      PMCID: PMC1489787          DOI: 10.1128/AAC.01652-05

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Plasmodium berghei: phase contrast and electron microscopical evidence that certain antimalarials can both inhibit and reverse pigment clumping caused by chloroquine.

Authors:  A Einheber; D M Palmer; M Aikawa
Journal:  Exp Parasitol       Date:  1976-08       Impact factor: 2.011

2.  Ingestion of erythrocytic stroma by Plasmodium chabaudi trophozoites: ultrastructural study by serial sectioning and 3-dimensional reconstruction.

Authors:  C Slomianny; G Prensier; P Charet
Journal:  Parasitology       Date:  1985-06       Impact factor: 3.234

3.  Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite.

Authors:  M Aikawa; L H Miller; J Johnson; J Rabbege
Journal:  J Cell Biol       Date:  1978-04       Impact factor: 10.539

4.  Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials.

Authors:  S Zarchin; M Krugliak; H Ginsburg
Journal:  Biochem Pharmacol       Date:  1986-07-15       Impact factor: 5.858

5.  Interaction of hemoglobin derivatives with liposomes. Membrane cholesterol protects against the changes of hemoglobin.

Authors:  J Szebeni; H Hauser; C D Eskelson; R R Watson; K H Winterhalter
Journal:  Biochemistry       Date:  1988-08-23       Impact factor: 3.162

6.  Denatured hemoglobin in sickle erythrocytes.

Authors:  T Asakura; K Minakata; K Adachi; M O Russell; E Schwartz
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

7.  Hemolysis of mouse erythrocytes by ferriprotoporphyrin IX and chloroquine. Chemotherapeutic implications.

Authors:  A C Chou; C D Fitch
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

8.  Red cell membrane protein distribution during malarial invasion.

Authors:  A R Dluzewski; P R Fryer; S Griffiths; R J Wilson; W B Gratzer
Journal:  J Cell Sci       Date:  1989-04       Impact factor: 5.285

9.  Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine.

Authors:  A Yayon; Z I Cabantchik; H Ginsburg
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

10.  Antimalarials increase vesicle pH in Plasmodium falciparum.

Authors:  D J Krogstad; P H Schlesinger; I Y Gluzman
Journal:  J Cell Biol       Date:  1985-12       Impact factor: 10.539

View more
  4 in total

1.  In vivo splenic clearance correlates with in vitro deformability of red blood cells from Plasmodium yoelii-infected mice.

Authors:  Sha Huang; Anburaj Amaladoss; Min Liu; Huichao Chen; Rou Zhang; Peter R Preiser; Ming Dao; Jongyoon Han
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Analysis of gene mutations involved in chloroquine resistance in Plasmodium falciparum parasites isolated from patients in the southwest of Saudi Arabia.

Authors:  Saad M Bin Dajem; Ahmed Al-Qahtani
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

3.  Novel antimalarial aminoquinolines: heme binding and effects on normal or Plasmodium falciparum-parasitized human erythrocytes.

Authors:  Fausta Omodeo-Salè; Lucia Cortelezzi; Nicoletta Basilico; Manolo Casagrande; Anna Sparatore; Donatella Taramelli
Journal:  Antimicrob Agents Chemother       Date:  2009-08-03       Impact factor: 5.191

Review 4.  1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents.

Authors:  Didier Belorgey; Don Antoine Lanfranchi; Elisabeth Davioud-Charvet
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.